Public Profile

Pharmanutra

Pharmanutra S.p.A., headquartered in Italy, is a leading player in the nutraceutical and pharmaceutical industry, specialising in the development of innovative dietary supplements and medical devices. Founded in 2003, the company has achieved significant milestones, including the introduction of its flagship product, SiderAL, which is renowned for its unique formulation of iron and its high bioavailability. With a strong presence in Europe and expanding operations in international markets, Pharmanutra is committed to enhancing health and well-being through scientifically-backed solutions. The company’s core offerings, including SiderAL and other mineral-based supplements, are distinguished by their patented technologies and rigorous clinical research. Recognised for its excellence, Pharmanutra continues to solidify its market position as a trusted provider of high-quality health products, contributing to advancements in nutritional science.

DitchCarbon Score

How does Pharmanutra's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

33

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

33

Industry Benchmark

Pharmanutra's score of 33 is higher than 63% of the industry. This can give you a sense of how well the company is doing compared to its peers.

63%

Let us know if this data was useful to you

Pharmanutra's reported carbon emissions

In 2023, Pharmanutra reported total carbon emissions of approximately 1,182,014 kg CO2e. This figure includes 229,189 kg CO2e from Scope 1 emissions, 270,515 kg CO2e from Scope 2 emissions (market-based), and significant Scope 3 emissions of 751,110 kg CO2e, which comprise 684,328 kg CO2e from business travel and 86,782 kg CO2e from employee commuting. Pharmanutra's emissions have shown fluctuations over the years. In 2022, the company recorded total emissions of about 199,150 kg CO2e for Scope 1 and 57,666 kg CO2e for Scope 2 (market-based). The previous year, 2021, saw Scope 1 emissions at 137,965 kg CO2e and Scope 2 emissions at 42,922 kg CO2e (market-based). In 2020, the company reported 92,590 kg CO2e for Scope 1 and 61,095 kg CO2e for Scope 2. Despite these figures, Pharmanutra has not disclosed specific reduction targets or initiatives aimed at decreasing their carbon footprint. The absence of defined climate pledges or science-based targets indicates a potential area for improvement in their sustainability strategy. As the company continues to operate within the pharmaceutical industry, addressing carbon emissions will be crucial for aligning with global climate commitments and enhancing their environmental responsibility.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2020202120222023
Scope 1
92,590
000,000
000,000
000,000
Scope 2
61,095
00,000
00,000
000,000
Scope 3
-
-
-
000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Pharmanutra's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Pharmanutra is in IT, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Pharmanutra is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Pfizer

US
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Bayer

DE
Chemicals nec
Updated 3 days ago

Transaction Holdings

US
Updated 4 months ago
DitchCarbon Score

King Pharmaceuticals LLC

US
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Procter And Gamble

US
Chemicals nec
Updated 3 days ago

Chiesi Farmaceutici

IT
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers